Shares of ResMed Inc. RMD shed 2.71% to $232.98 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.01% to 6,114.63 and Dow ...

Shares of ResMed Inc. RMD advanced 1.44% to $239.48 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 1.04% to 6,115.07 and ...

Medical device company DexCom (NASDAQ:DXCM) will be reporting earnings tomorrow after the bell. Here’s what investors should ...

The Australian share market looks set to tumble on Monday. Here's what you need to know. The post 5 things to watch on the ...

Kristen Bell knows how hard it can be to fit exercise into a busy schedule. During our Zoom call, we realize we're both missing our regular workouts to do this interview — it's Monday evening in ...

ResMed Inc. (NYSE:RMD – Free Report) – Equities research analysts at Zacks Research raised their Q2 2025 earnings estimates for ResMed in a research report issued on Wednesday, January 29th.

RYE BROOK, N.Y., Jan. 31, 2025 /PRNewswire/ -- Celebrating its 75th year of progress toward its mission to cure blood cancer and improve the quality of life of all patients and their families, The ...

"Every day, blood cancer patients ring the bell marking milestones in their treatment. Thanks to scientific innovation, patient support and advocacy fueled by LLS over 75 years, today we ring the ...

ResMed (NYSE:RMD), a leader in sleep apnea and respiratory care solutions, reported strong fiscal 2025 second-quarter earnings on Thursday, Jan. 30. The medical device company outperformed analyst ...

In late trade on Wall Street, the Dow Jones is up 0.55%, the S&P 500 is up 0.55%, and the Nasdaq is 0.2% higher ... tariffs on Canada and Mexico. ResMed Inc. (ASX: RMD) shares will be on watch ...

Australian shares are set to open up. The Nasdaq was held back by a slump in Microsoft. ECB cuts key rate. Follow updates here.